M. Biour, B. Salem, C. Chazouillères, and O. , H??patotoxicit?? des m??dicaments 14e mise ?? jour du fichier bibliographique des atteintes h??patiques et des m??dicaments responsables, Gastroent??rologie Clinique et Biologique, vol.28, issue.8-9, pp.720-759, 2004.
DOI : 10.1016/S0399-8320(04)95062-2

R. Ramachandran and S. Kakar, Histological patterns in drug-induced liver disease, Journal of Clinical Pathology, vol.62, issue.6, pp.481-492, 2009.
DOI : 10.1136/jcp.2008.058248

B. Fromenty and D. Pessayre, Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity, Pharmacology & Therapeutics, vol.67, issue.1, pp.101-154, 1995.
DOI : 10.1016/0163-7258(95)00012-6

G. Labbe, D. Pessayre, and B. Fromenty, Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies, Fundamental & Clinical Pharmacology, vol.287, issue.Suppl 2, pp.335-353, 2008.
DOI : 10.1111/j.1472-8206.2008.00608.x

K. Begriche, J. Massart, and M. Robin, Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver, Journal of Hepatology, vol.54, issue.4, pp.773-794, 2011.
DOI : 10.1016/j.jhep.2010.11.006
URL : https://hal.archives-ouvertes.fr/hal-00739371

D. Pessayre, A. Mansouri, and A. Berson, Mitochondrial Involvement in Drug-Induced Liver Injury, Handb Exp Pharmacol, vol.196, pp.311-365, 2010.
DOI : 10.1007/978-3-642-00663-0_11
URL : https://hal.archives-ouvertes.fr/hal-00742326

D. Pessayre, B. Fromenty, and A. Berson, Central role of mitochondria in drug-induced liver injury, Drug Metabolism Reviews, vol.52, issue.2, pp.34-87, 2012.
DOI : 10.1124/jpet.109.156331
URL : https://hal.archives-ouvertes.fr/hal-00866123

D. Wallace, W. Fan, and V. Procaccio, Mitochondrial Energetics and Therapeutics, Annual Review of Pathology: Mechanisms of Disease, vol.5, issue.1, pp.297-348, 2010.
DOI : 10.1146/annurev.pathol.4.110807.092314
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245719

K. Begriche, J. Massart, and M. Robin, Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease, Hepatology, vol.6, issue.4, 2013.
DOI : 10.1002/hep.26226
URL : https://hal.archives-ouvertes.fr/inserm-00814080

P. Shekhawat, D. Matern, and A. Strauss, Fetal Fatty Acid Oxidation Disorders, Their Effect on Maternal Health and Neonatal Outcome: Impact of Expanded Newborn Screening on Their Diagnosis and Management, Pediatric Research, vol.47, issue.5 Part 2, pp.78-86, 2005.
DOI : 10.1203/01.PDR.0000159631.63843.3E

L. Knockaert, V. Descatoire, and N. Vadrot, Mitochondrial CYP2E1 is sufficient to mediate oxidative stress and cytotoxicity induced by ethanol and acetaminophen, Toxicology in Vitro, vol.25, issue.2, pp.475-484, 2011.
DOI : 10.1016/j.tiv.2010.11.019
URL : https://hal.archives-ouvertes.fr/hal-00739823

Q. Huang, J. X. Gaillard, and E. , Gene expression profiling reveals multiple toxicity endpoints induced by hepatotoxicants, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.549, issue.1-2, pp.147-167, 2004.
DOI : 10.1016/j.mrfmmm.2003.12.020

H. Yohe, O. Hara, K. Hunt, and J. , Involvement of Toll-like receptor 4 in acetaminophen hepatotoxicity, AJP: Gastrointestinal and Liver Physiology, vol.290, issue.6, pp.1269-1279, 2006.
DOI : 10.1152/ajpgi.00239.2005

J. Aubert, K. Begriche, and M. Delannoy, Differences in Early Acetaminophen Hepatotoxicity between Obese ob/ob and db/db Mice, Journal of Pharmacology and Experimental Therapeutics, vol.342, issue.3, pp.676-687, 2012.
DOI : 10.1124/jpet.112.193813
URL : https://hal.archives-ouvertes.fr/inserm-00864718

J. Kennedy, S. Unger, and J. Horowitz, Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone, Biochemical Pharmacology, vol.52, issue.2, pp.273-280, 1996.
DOI : 10.1016/0006-2952(96)00204-3

J. Fulgencio, C. Kohl, and J. Girard, Troglitazone Inhibits Fatty Acid Oxidation and Esterification, and Gluconeogenesis in Isolated Hepatocytes from Starved Rats, Diabetes, vol.45, issue.11, pp.1556-1562, 1996.
DOI : 10.2337/diab.45.11.1556

D. Deschamps, C. Fisch, and B. Fromenty, Inhibition by salicylic acid of the activation and thus oxidation of long chain fatty acids. Possible role in the development of Reye's syndrome, J Pharmacol Exp Ther, vol.259, pp.894-904, 1991.

P. Luís, J. Ruiter, and R. Ofman, Valproic acid utilizes the isoleucine breakdown pathway for its complete ??-oxidation, Biochemical Pharmacology, vol.82, issue.11, pp.1740-1746, 2011.
DOI : 10.1016/j.bcp.2011.07.103

A. Berson, D. Fau, and R. Fornacciari, Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation, Journal of Hepatology, vol.34, issue.2, pp.261-269, 2001.
DOI : 10.1016/S0168-8278(00)00050-7

E. Fréneaux, G. Labbe, and P. Letteron, Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic, Hepatology, vol.79, issue.5, pp.1056-1062, 1988.
DOI : 10.1002/hep.1840080513

G. Labbe, B. Fromenty, and E. Freneaux, Effects of various tetracycline derivatives on in vitro and in vivo ??-oxidation of fatty acids, egress of triglycerides from the liver, accumulation of hepatic triglycerides, and mortality in mice, Biochemical Pharmacology, vol.41, issue.4, pp.638-641, 1991.
DOI : 10.1016/0006-2952(91)90640-Q

H. Yu, B. Wang, and J. Zhao, Protective effect of bicyclol on tetracycline-induced fatty liver in mice, Toxicology, vol.261, issue.3, pp.112-118, 2009.
DOI : 10.1016/j.tox.2009.04.058

M. Cuenca-lopez, A. Karachitos, and L. Massarotto, Minocycline exerts uncoupling and inhibiting effects on mitochondrial respiration through adenine nucleotide translocase inhibition, Pharmacological Research, vol.65, issue.1, pp.120-128, 2012.
DOI : 10.1016/j.phrs.2011.08.007

W. Abdel-razaq, D. Kendall, and T. Bates, The Effects of Antidepressants on Mitochondrial Function in a Model Cell System and Isolated Mitochondria, Neurochemical Research, vol.89, issue.3, pp.327-338, 2011.
DOI : 10.1007/s11064-010-0331-z

F. Degoul, A. Sutton, and A. Mansouri, Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease, Gastroenterology, vol.120, issue.6, pp.1468-1474, 2001.
DOI : 10.1053/gast.2001.24051

U. Boelsterli and C. Hsiao, The heterozygous Sod2+/??? mouse: modeling the mitochondrial role in drug toxicity, Drug Discovery Today, vol.13, issue.21-22, pp.982-988, 2008.
DOI : 10.1016/j.drudis.2008.08.002

K. Begriche, P. Lettéron, and A. Abbey-toby, Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice, AJP: Endocrinology and Metabolism, vol.294, issue.5, pp.939-951, 2008.
DOI : 10.1152/ajpendo.00379.2007

G. Farrell, Drugs and steatohepatitis. Semin Liver Dis, pp.185-194, 2002.
DOI : 10.1055/s-2002-30106

L. Grismer, S. Gill, and M. Harris, Liver Biopsy in Psoriatic Arthritis to Detect Methotrexate Hepatotoxicity, JCR: Journal of Clinical Rheumatology, vol.7, issue.4, pp.224-227, 2001.
DOI : 10.1097/00124743-200108000-00007

D. Zorzi, A. Laurent, and T. Pawlik, Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases, British Journal of Surgery, vol.13, issue.3, pp.274-286, 2007.
DOI : 10.1002/bjs.5719

A. Berson, D. Beco, V. Lettéron, and P. , Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes, Gastroenterology, vol.114, issue.4, pp.764-774, 1998.
DOI : 10.1016/S0016-5085(98)70590-6

C. Mitchell, M. Mahrouf-yorgov, and A. Mayeuf, Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease, Laboratory Investigation, vol.284, issue.2, pp.273-282, 2011.
DOI : 10.1038/labinvest.2010.163
URL : https://hal.archives-ouvertes.fr/hal-00740125

L. Brady, P. Brady, and D. Romsos, ) mice, Biochemical Journal, vol.231, issue.2, pp.439-444, 1985.
DOI : 10.1042/bj2310439

T. Takamura, A. Shimizu, and T. Komura, Selective Estrogen Receptor Modulator Raloxifene-Associated Aggravation of Nonalcoholic Steatohepatitis, Internal Medicine, vol.46, issue.9, pp.579-581, 2007.
DOI : 10.2169/internalmedicine.46.6374

A. Igoudjil, J. Massart, and K. Begriche, High concentrations of stavudine impair fatty acid oxidation without depleting mitochondrial DNA in cultured rat hepatocytes, Toxicology in Vitro, vol.22, issue.4, pp.887-898, 2008.
DOI : 10.1016/j.tiv.2008.01.011

E. Martins-maciel, L. Campos, and C. Salgueiro-pagadigorria, Raloxifene affects fatty acid oxidation in livers from ovariectomized rats by acting as a pro-oxidant agent, Toxicology Letters, vol.217, issue.1, pp.82-89, 2013.
DOI : 10.1016/j.toxlet.2012.11.021

R. Nazarewicz, W. Zenebe, and A. Parihar, Tamoxifen Induces Oxidative Stress and Mitochondrial Apoptosis via Stimulating Mitochondrial Nitric Oxide Synthase, Cancer Research, vol.67, issue.3, pp.1282-1290, 2007.
DOI : 10.1158/0008-5472.CAN-06-3099

K. Singh, A. Malviya, and M. Bhori, An in vitro study of the ameliorative role of ??-tocopherol on methotrexate-induced oxidative stress in rat heart mitochondria, Journal of Basic and Clinical Physiology and Pharmacology, vol.23, issue.4, pp.163-168, 2012.
DOI : 10.1515/jbcpp-2012-0020

L. Cole, R. Jacobs, and D. Vance, Tamoxifen induces triacylglycerol accumulation in the mouse liver by activation of fatty acid synthesis, Hepatology, vol.10, issue.4, pp.1258-1265, 2010.
DOI : 10.1002/hep.23813

J. Hynes, R. Swiss, and Y. Will, High-Throughput Analysis of Mitochondrial Oxygen Consumption, Methods Mol Biol, vol.810, pp.59-72, 2012.
DOI : 10.1007/978-1-61779-382-0_4

S. Robinson, C. Wilson, and A. Burt, Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis, Annals of Surgical Oncology, vol.31, issue.942, pp.4287-99, 2012.
DOI : 10.1245/s10434-012-2438-8

Y. Wang, Z. Lin, and Z. Liu, A Unifying Ontology to Integrate Histological and Clinical Observations for Drug-Induced Liver Injury, The American Journal of Pathology, vol.182, issue.4, pp.1180-1187, 2013.
DOI : 10.1016/j.ajpath.2012.12.033
URL : http://doi.org/10.1016/j.ajpath.2012.12.033